iTolerance

We are deeply saddened by the tragic and unexpected passing of our CEO and President, Anthony Japour. Anthony was not only a remarkable leader, but also someone whose warmth, generosity, and unwavering support left a lasting impact on all of us. Our hearts are with his family and loved ones during this incredibly difficult time. He will be deeply missed and forever remembered.

Patient-first science powering regenerative breakthroughs for chronic disease.

Discover what sets iTolerance apart.

iTolerance is pioneering regenerative medicine without the need for life-long immunosuppression.

Our proprietary platform enables cell, organoid or tissue therapies with the potential to cure diseases like and beyond.

Take a deeper dive into our science!
Check out our scientific publications here: https://bit.ly/3YAUqcl

Happy New Year from iTolerance! May 2026 bring you success and good health.